Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study
作者: Emi DikaGiulia Maria RavaioliPier Alessandro FantiBianca Maria PiracciniMartina LambertiniMarco Adriano ChessaCarlotta BaraldiSimone RiberoArdizzoni AndreaBarbara MelottiAnnalisa Patrizi
作者单位: 1University of Bologna
2University of Turin
刊名: European Journal of Dermatology, 2017, Vol.27 (3), pp.266-270
来源数据库: Springer Journal
DOI: 10.1684/ejd.2017.3023
关键词: IpilimumabAdverse eventsMelanomaTreatment
英文摘要: Ipilimumab is an immunomodulatory antibody directed against cytotoxicT-lymphocyte-associated antigen 4 (CTLA-4), which is administered to patients with advanced melanoma, with a proven positive effect on overall survival. The cutaneous adverse effects (AEs) of ipilimumab are relatively frequent, although described as usually mild and rarely life threatening.
原始语种摘要: Ipilimumab is an immunomodulatory antibody directed against cytotoxicT-lymphocyte-associated antigen 4 (CTLA-4), which is administered to patients with advanced melanoma, with a proven positive effect on overall survival. The cutaneous adverse effects (AEs) of ipilimumab are relatively frequent, although described as usually mild and rarely life threatening.
全文获取路径: Springer  (合作)
分享到:
来源刊物:
影响因子:1.756 (2012)

×
关键词翻译
关键词翻译
  • melanoma 黑瘤
  • adverse 逆的
  • lymphocyte 淋巴细胞
  • metastatic 新陈代谢的
  • prospective 远景
  • antibody 抗体
  • effects 海员自身物品
  • events 定时
  • proven 证明
  • survival 生存